The test measures a specific protein and was able to identify two thirds of patients who had pancreatic cancer at an early stage of their disease.
Any means of spotting pancreatic cancer early is critical.
The types of pancreatic cancer spotted were by far the most common form of the disease.
The data was presented at the Gastrointestinal Cancers Symposium in San Francisco.